The objective of this study is to examine the effects of methionine restriction on triple negative breast cancer and to establish the feasibility and acceptability of this intervention in breast cancer patients. Non-contrast MRIs will be used to evaluate the effect of methionine restriction on body composition before and after the intervention.
This project was led by: Ruth O'Regan MD
This project was funded by: AVON Foundation
The term of this project was: August 2017 to July 2018
The number of subjects scanned during this project was: 25